133 related articles for article (PubMed ID: 38419312)
1. Regression of Necrotic Lesions after Methotrexate Withdrawal in Patients with Methotrexate-Associated Lymphoproliferative Disorders: A Retrospective CT Study.
Kitayama T; Tanaka T; Kanie Y; Marukawa Y; Kojima K; Tanaka T; Takao S; Hiraki T
Acta Med Okayama; 2024 Feb; 78(1):29-36. PubMed ID: 38419312
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
Watanabe S; Manabe O; Hirata K; Oyama-Manabe N; Hattori N; Kikuchi Y; Kobayashi K; Toyonaga T; Tamaki N
BMC Cancer; 2016 Aug; 16():635. PubMed ID: 27528380
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders.
Takanashi S; Nakazato T; Aisa Y; Ito C; Arakaki H; Osada Y; Hirano M; Mori T
Ann Hematol; 2018 Sep; 97(9):1611-1618. PubMed ID: 29713747
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.
Ikeda K; Nakamura T; Kinoshita T; Fujiwara M; Uose S; Someda H; Miyoshi T; Io K; Nagai K
Clin J Gastroenterol; 2016 Feb; 9(1):17-21. PubMed ID: 26733461
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression.
Takanashi S; Aisa Y; Ito C; Arakaki H; Osada Y; Amano Y; Hirano M; Nakazato T
Rheumatol Int; 2017 Oct; 37(10):1629-1633. PubMed ID: 28676912
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.
Kobayashi Y; Kimura K; Fujitsu Y; Shinkawa K; Muta H; Sonoda KH
Jpn J Ophthalmol; 2016 May; 60(3):212-8. PubMed ID: 27018050
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-associated lymphoproliferative disorder with an osteolytic vertebral lesion in an elderly patient with rheumatoid arthritis: A case report.
Hirata C; Kenzaka T; Akita H
J Clin Pharm Ther; 2021 Aug; 46(4):1178-1181. PubMed ID: 33768586
[TBL] [Abstract][Full Text] [Related]
8. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: A case report.
Omameuda T; Miyato H; Sata N; Lefor AK
Medicine (Baltimore); 2022 Nov; 101(47):e31993. PubMed ID: 36451467
[TBL] [Abstract][Full Text] [Related]
9. The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders.
Tokuhira M; Tanaka Y; Takahashi Y; Kimura Y; Tomikawa T; Anan T; Watanabe J; Sagawa M; Higashi M; Momose S; Amano K; Tabayashi T; Nakaseko R; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2020 Jun; 60(2):41-50. PubMed ID: 32404570
[TBL] [Abstract][Full Text] [Related]
10. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate.
Saito S; Kaneko Y; Yamaoka K; Tokuhira M; Takeuchi T
Rheumatology (Oxford); 2017 Jun; 56(6):940-946. PubMed ID: 28165538
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
Toyonaga H; Fukushima M; Shimeno N; Inokuma T
BMC Gastroenterol; 2019 Apr; 19(1):62. PubMed ID: 31023238
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate-Associated Lymphoproliferative Disorders Mimicking Granulomatosis With Polyangiitis: A Radiological Diagnostic Challenge.
Tachibana T; Sasaki T; Wani Y; Komatsubara Y; Kuroda K; Naoi Y; Gion Y; Orita Y; Nishizaki K; Sato Y
Ear Nose Throat J; 2022 Sep; 101(8):NP362-NP366. PubMed ID: 33155857
[TBL] [Abstract][Full Text] [Related]
13. Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
Nakano K; Saito K; Nawata A; Hanami K; Kubo S; Miyagawa I; Fujino Y; Nakayamada S; Tanaka Y
Mod Rheumatol; 2021 Jan; 31(1):94-100. PubMed ID: 32159414
[TBL] [Abstract][Full Text] [Related]
14. [Methotrexate-associated lymphoproliferative disorders: clinical aspects].
Tokuhira M; Kizaki M
Rinsho Ketsueki; 2019; 60(8):932-943. PubMed ID: 31484893
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate-associated lymphoproliferative disorder with multiple pulmonary nodules and bilateral cervical lymphadenopathy.
Makihara S; Kariya S; Noujima-Harada M; Ohara N; Naito T; Matsumoto J; Noda Y; Okano M; Yoshino T; Nishizaki K
Auris Nasus Larynx; 2019 Dec; 46(6):927-933. PubMed ID: 30739816
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of methotrexate-associated lymphoproliferative disorders in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs.
Harada T; Iwasaki H; Muta T; Urata S; Sakamoto A; Kohno K; Takase K; Miyamura T; Sawabe T; Asaoku H; Oryoji K; Fujisaki T; Mori Y; Yoshimoto G; Ayano M; Mitoma H; Miyamoto T; Niiro H; Yamamoto H; Oshiro Y; Miyoshi H; Ohshima K; Takeshita M; Akashi K; Kato K
Br J Haematol; 2021 Jul; 194(1):101-110. PubMed ID: 33822354
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.
Kurita D; Miyoshi H; Ichikawa A; Kato K; Imaizumi Y; Seki R; Sato K; Sasaki Y; Kawamoto K; Shimono J; Yamada K; Muto R; Kizaki M; Nagafuji K; Tamaru JI; Tokuhira M; Ohshima K
Am J Surg Pathol; 2019 Jul; 43(7):869-884. PubMed ID: 31116708
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
[TBL] [Abstract][Full Text] [Related]
20. Endobronchial Manifestation of Methotrexate-induced Lymphoproliferative Disorder.
Ikeue T; Kawachi H; Yoshida H; Tanaka E; Noguchi S; Fukao A; Terashita S; Tajiri T; Horikawa S; Sugita T
Intern Med; 2019 Jun; 58(11):1597-1603. PubMed ID: 30713318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
